# Filing Detail

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-24-052092
Filing Date
2024-05-02
Accepted
2024-05-02 16:07:23
Documents
53
Period of Report
2024-03-31

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 10-Q | life-20240331.htm iXBRL | 10-Q | 1501656
2 | EX-10.1 | life-ex10_1.htm | EX-10.1 | 80902
3 | EX-31.1 | life-ex31_1.htm | EX-31.1 | 11023
4 | EX-31.2 | life-ex31_2.htm | EX-31.2 | 11079
5 | EX-32.1 | life-ex32_1.htm | EX-32.1 | 7644
6 | EX-32.2 | life-ex32_2.htm | EX-32.2 | 7164
| Complete submission text file | 0000950170-24-052092.txt |  | 6349679

Data Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
7 | XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT | life-20240331.xsd | EX-101.SCH | 1085753
56 | EXTRACTED XBRL INSTANCE DOCUMENT | life-20240331_htm.xml | XML | 914079

Mailing Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121
Business Address 10240 SORRENTO VALLEY ROAD SUITE 300 SAN DIEGO CA 92121 8587318389
aTYR PHARMA INC (Filer) CIK: 0001339970 (see all company filings)

EIN.: 203435077 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37378 | Film No.: 24908210
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)